TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT05287867: Trial for Treating Painful Degenerative Disc Disease

Sponsor: Regenexx, LLC · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 42 pts

Competing Trials Overlap

4 Active Trials

Excess Burn Exposure

$3,984,000

Rescue Site Savings

+$2,622,800

Unlock Full NCT05287867 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05287867 Rescue Dossier →